Therapeutic competitions and frailty among older adults in São Paulo city: a cross-sectional population-based study, 2015.

IF 2 Q1 Multidisciplinary
Epidemiologia e Servicos de Saude Pub Date : 2025-04-11 eCollection Date: 2025-01-01 DOI:10.1590/S2237-96222025v34e20240104.en
Igor Gonçalves de Souza, Yeda Aparecida de Oliveira Duarte, Mariana Martins Gonzaga do Nascimento, Caroline de Godoi Rezende Costa Molino, Cristiane de Paula Rezende, Jair Lício Ferreira Santos
{"title":"Therapeutic competitions and frailty among older adults in São Paulo city: a cross-sectional population-based study, 2015.","authors":"Igor Gonçalves de Souza, Yeda Aparecida de Oliveira Duarte, Mariana Martins Gonzaga do Nascimento, Caroline de Godoi Rezende Costa Molino, Cristiane de Paula Rezende, Jair Lício Ferreira Santos","doi":"10.1590/S2237-96222025v34e20240104.en","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To identify the presence of therapeutic competitions according to the frailty component classification and to assess association between therapeutic competitions and frailty in people aged 60 or over in the city of São Paulo, Brazil.</p><p><strong>Methods: </strong>This was a population-based cross-sectional study. Frailty was identified when three to five components defined by Fried were present, and pre-frailty was identified when one or two were present. Therapeutic competitions were characterized by use of medication for a specific chronic non-communicable disease that negatively affects another disease. We used multinomial logistic regression.</p><p><strong>Results: </strong>Therapeutic competitions were identified for 13.2% of the 1,224 participants. Of this total, 18.7% were considered to be frail individuals. The most prevalent therapeutic competition involved diabetes and cardiovascular disease (4.2% of the total and 6.8% of frail people) with metformin or angiotensin-converting enzyme inhibitors. The presence of two therapeutic competitions in individuals with multimorbidity increased the likelihood of pre-frailty (odds ratio 2.51; 95% confidence interval 1.10; 5.76).</p><p><strong>Conclusion: </strong>Therapeutic competitions are common in the elderly population and more frequent among frail elderly people, with increased likelihood of pre-frailty when two therapeutic competitions are present.</p>","PeriodicalId":51473,"journal":{"name":"Epidemiologia e Servicos de Saude","volume":"34 ","pages":"e20240104"},"PeriodicalIF":2.0000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11998657/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiologia e Servicos de Saude","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/S2237-96222025v34e20240104.en","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Multidisciplinary","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To identify the presence of therapeutic competitions according to the frailty component classification and to assess association between therapeutic competitions and frailty in people aged 60 or over in the city of São Paulo, Brazil.

Methods: This was a population-based cross-sectional study. Frailty was identified when three to five components defined by Fried were present, and pre-frailty was identified when one or two were present. Therapeutic competitions were characterized by use of medication for a specific chronic non-communicable disease that negatively affects another disease. We used multinomial logistic regression.

Results: Therapeutic competitions were identified for 13.2% of the 1,224 participants. Of this total, 18.7% were considered to be frail individuals. The most prevalent therapeutic competition involved diabetes and cardiovascular disease (4.2% of the total and 6.8% of frail people) with metformin or angiotensin-converting enzyme inhibitors. The presence of two therapeutic competitions in individuals with multimorbidity increased the likelihood of pre-frailty (odds ratio 2.51; 95% confidence interval 1.10; 5.76).

Conclusion: Therapeutic competitions are common in the elderly population and more frequent among frail elderly people, with increased likelihood of pre-frailty when two therapeutic competitions are present.

Abstract Image

Abstract Image

2015年,圣保罗市老年人的治疗竞争和虚弱:一项基于人口的横断面研究。
目的:根据衰弱成分分类确定治疗性竞争的存在,并评估巴西圣保罗市60岁及以上人群中治疗性竞争与衰弱的关系。方法:这是一项基于人群的横断面研究。当弗里德定义的三到五个成分存在时,就会识别出脆弱性,当一到两个成分存在时,就会识别出预脆弱性。治疗竞争的特点是使用对另一种疾病产生负面影响的特定慢性非传染性疾病的药物。我们使用多项逻辑回归。结果:在1224名参与者中,有13.2%的人存在治疗竞争。其中,18.7%被认为是体弱个体。最普遍的治疗竞争涉及糖尿病和心血管疾病(占总数的4.2%和虚弱者的6.8%)与二甲双胍或血管紧张素转换酶抑制剂。在多病个体中存在两种治疗竞争增加了前衰弱的可能性(优势比2.51;95%置信区间1.10;5.76)。结论:治疗性竞争在老年人群中很常见,在体弱多病的老年人中更为常见,当两种治疗性竞争同时存在时,出现前衰弱的可能性增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Epidemiologia e Servicos de Saude
Epidemiologia e Servicos de Saude PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
4.90
自引率
0.00%
发文量
88
审稿时长
21 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信